JP2016505534A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016505534A5 JP2016505534A5 JP2015543399A JP2015543399A JP2016505534A5 JP 2016505534 A5 JP2016505534 A5 JP 2016505534A5 JP 2015543399 A JP2015543399 A JP 2015543399A JP 2015543399 A JP2015543399 A JP 2015543399A JP 2016505534 A5 JP2016505534 A5 JP 2016505534A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12193311.3 | 2012-11-20 | ||
| EP12193311 | 2012-11-20 | ||
| PCT/EP2013/074012 WO2014079787A1 (en) | 2012-11-20 | 2013-11-18 | Substituted 1,6-naphthyridines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016505534A JP2016505534A (ja) | 2016-02-25 |
| JP2016505534A5 true JP2016505534A5 (enExample) | 2017-01-05 |
Family
ID=47189816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015543399A Pending JP2016505534A (ja) | 2012-11-20 | 2013-11-18 | 置換１，６−ナフチリジン |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9657014B2 (enExample) |
| EP (1) | EP2922540A1 (enExample) |
| JP (1) | JP2016505534A (enExample) |
| KR (1) | KR20150085538A (enExample) |
| CN (1) | CN104812387A (enExample) |
| AR (1) | AR093519A1 (enExample) |
| BR (1) | BR112015011094A2 (enExample) |
| CA (1) | CA2890685A1 (enExample) |
| HK (1) | HK1207317A1 (enExample) |
| MX (1) | MX2015006364A (enExample) |
| RU (1) | RU2015120217A (enExample) |
| TW (1) | TW201425312A (enExample) |
| WO (1) | WO2014079787A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI529171B (zh) | 2013-07-29 | 2016-04-11 | 赫孚孟拉羅股份公司 | １，７－萘啶衍生物 |
| WO2016009076A1 (en) * | 2014-07-17 | 2016-01-21 | Merck Patent Gmbh | Novel naphthryidines and isoquinolines and their use as cdk8/19 inhibitors |
| CA2974874A1 (en) * | 2015-02-11 | 2016-08-18 | Basilea Pharmaceutica International AG | Substituted mono- and polyazanaphthalene derivatives and their use |
| SG11201706869XA (en) | 2015-03-24 | 2017-09-28 | Shanghai Yingli Pharm Co Ltd | Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof |
| EP3371164B1 (en) * | 2015-11-06 | 2022-03-16 | Neurocrine Biosciences, Inc. | N-[2-(1-benzylpiperidin-4-yl)ethyl]-4-(pyrazin-2-yl)-piperazine-1-carboxamide derivatives and related compounds as muscarinic receptor 4 (m4) antagonists for treating neurological diseases |
| EA039638B1 (ru) * | 2016-01-06 | 2022-02-21 | Нейрокрин Байосайенсиз, Инк. | Антагонисты мускаринового рецептора 4 и способы их применения |
| WO2018159805A1 (ja) | 2017-03-03 | 2018-09-07 | 国立大学法人京都大学 | 膵前駆細胞の製造方法 |
| MX2021008152A (es) | 2019-01-03 | 2021-10-13 | Univ Pittsburgh Commonwealth Sys Higher Education | Metodos y materiales para aumentar los niveles del polipeptido del factor de transcripcion eb. |
| EP4069367B1 (en) | 2019-12-06 | 2024-05-15 | Neurocrine Biosciences, Inc. | Muscarinic receptor 4 antagonists and methods of use |
| AU2021401429A1 (en) * | 2020-12-18 | 2023-07-06 | The Scripps Research Institute | Compounds and use thereof for treatment of neurodegenerative, degenerative and metabolic disorders |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9605437D0 (en) | 1996-03-15 | 1996-05-15 | Iaf Biochem Int | Cytomegalovirus inhibiting compounds |
| US6255318B1 (en) * | 1997-12-11 | 2001-07-03 | Biochem Pharma Inc. | Antiviral compounds |
| AU2002218902A1 (en) | 2000-12-27 | 2002-07-08 | Shire Biochem Inc. | Macrocyclic anti-viral compounds |
| CA2575571A1 (en) | 2004-08-03 | 2006-02-16 | Serenex, Inc. | 2,8-disubstituted naphthyridine derivatives |
| FR2904317A1 (fr) | 2006-07-27 | 2008-02-01 | Inst Nat Sante Rech Med | Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques |
| US20080242694A1 (en) | 2006-09-18 | 2008-10-02 | D Sidocky Neil R | Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith |
| WO2008046072A2 (en) | 2006-10-13 | 2008-04-17 | The Board Of Regents Of The University Of Texas System | Chemical inducers of neurogenesis |
| EP2380878B1 (en) | 2009-01-19 | 2013-08-14 | Daiichi Sankyo Company, Limited | Cyclic compound having hetero atom |
| WO2010101949A1 (en) | 2009-03-02 | 2010-09-10 | Sirtris Pharmaceuticals, Inc. | 8-substituted quinolines and related analogs as sirtuin modulators |
| KR20120006016A (ko) * | 2009-04-06 | 2012-01-17 | 다이이찌 산쿄 가부시키가이샤 | 치환 페닐기를 갖는 고리형 화합물 |
| CN103415289B (zh) | 2010-07-07 | 2017-04-12 | 得克萨斯州大学系统董事会 | 前神经原性化合物 |
| JP2012036168A (ja) | 2010-07-15 | 2012-02-23 | Daiichi Sankyo Co Ltd | ヘテロ原子を有する環状化合物を含有する医薬組成物 |
-
2013
- 2013-11-18 MX MX2015006364A patent/MX2015006364A/es unknown
- 2013-11-18 AR ARP130104234A patent/AR093519A1/es unknown
- 2013-11-18 BR BR112015011094A patent/BR112015011094A2/pt not_active IP Right Cessation
- 2013-11-18 JP JP2015543399A patent/JP2016505534A/ja active Pending
- 2013-11-18 TW TW102141946A patent/TW201425312A/zh unknown
- 2013-11-18 CA CA2890685A patent/CA2890685A1/en not_active Abandoned
- 2013-11-18 HK HK15108069.2A patent/HK1207317A1/xx unknown
- 2013-11-18 EP EP13795705.6A patent/EP2922540A1/en not_active Withdrawn
- 2013-11-18 RU RU2015120217A patent/RU2015120217A/ru not_active Application Discontinuation
- 2013-11-18 CN CN201380060294.0A patent/CN104812387A/zh active Pending
- 2013-11-18 WO PCT/EP2013/074012 patent/WO2014079787A1/en not_active Ceased
- 2013-11-18 KR KR1020157016208A patent/KR20150085538A/ko not_active Ceased
-
2015
- 2015-05-20 US US14/717,109 patent/US9657014B2/en not_active Expired - Fee Related